Adenovirus-mediated gene therapy for head and neck squamous cell carcinomas

Annals of Otology, Rhinology and Laryngology

Volumn 105, Issue 7, 1996, Pages 562-567

  Davidson, Beverly L ^a   Graham, Scott M ^a   Goebel, Eric A ^a   Zabner, Joseph ^a   Kern, Jeffrey A ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

adenovirus; ganciclovir; gene transduction; herpes simplex virus thymidine kinase; squamous cell carcinoma

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ARTICLE; CELL DIVISION; CONTROLLED STUDY; GENE THERAPY; GENETIC TRANSDUCTION; HEAD AND NECK CARCINOMA; HERPES SIMPLEX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 8944253769     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949610500713     Document Type: Article

References (21)

1. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995;45:8-30.
2. Von Hoff DD. Head and neck cancer. In: Stein JH, ed. Internal medicine. New York, NY:Mosby- Year Book. 1994:9437.
3. Million RR, Cassisi NJ, Clark JR. Cancer of the head and neck. In: Devita VT Jr, Hellman S, Rosenberg SA. eds. Cancer, principles and practice of oncology. Philadelphia, Pa: JB Lippincott, 1989:488-590.
4. Merino OR, Lindberg RD, Fletcher GH. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1977;40:145-51.
5. Clayman GL, El-Naggar AK, Roth JA, et al. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 1995;55:1-6.
6. Vile R, Russell SJ. Gene transfer technologies for the gene therapy of cancer. Gene Ther 1994;1:88-98.
7. Cheng YC, Grill SP, Dutschman GE, Nakayama K, Bastow KF. Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in herpes simplex virus-infected cells. J Biol Chem 1983;258:12460-4.
8. Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 1993;53:83-8.
9. DiMaio JM, Clary BM, Via DF, Coveney E, Pappas TN, Lyerly HK. Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo. Surgery 1994;116:205-13.
10. Mulligan RC. The basic science of gene therapy. Science 1993;260:926-32.
11. Smythe WR, Hwang HC, Amin KM, et al. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res 1994;54:2055-9.
12. Chen SH. Shine HD, Goodman JC, Woo SL. Gene therapy for brain tumors: regression of experimental gliomas by adeno-virus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 1994;91:3054-7.
13. Shewach DS, Zerbe LK, Hughes TL, Roessler BJ, Breakefield XO, Davidson BL. Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells. Cancer Gene Ther 1994;1:107-12.
14. Simon RH, Engelhardt JF, Yang Y, et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum Gene Ther 1993;4:771-80.
15. Welsh MJ, Smith AE, Zabner J. et al. Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epithelium. Hum Gene Ther 1994;5:209-19.
16. Zabner J, Couture LA, Smith AE, Welsh MJ. Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: efficiency of adenovirus-mediated gene transfer in vitro. Hum Gene Ther 1994;5:585-93.
17. Rich DP, Couture LA, Cardoza LM, et al. Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis. Hum Gene Ther 1993;4:461-76.
18. Davidson BL, Allen ED, Kozarsky KF, Wilson JM, Roessler BJ. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet 1993;3:219-23.
19. Wan LB, Parysek LM, Warnick R, Stambrook PJ. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum Gene Ther 1993;4:725-31.
20. Freeman SM, Abboud CN, Whartenby KA, et al. The "bystandereffect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993;53:5274-83.
21. Laskin OL, Stahl-Bayliss CM, Kalman CM, Rosecan LR. Use of ganciclovir to treat serious cytomegalovirus infections in patients with AIDS. J Infect Dis 1987;155:323-7.